down arrow

Vanta Bioscience

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE695X01011
  • NSEID:
  • BSEID: 540729
INR
21.96
1.04 (4.97%)
BSENSE

Apr 11, 12:15 PM

BSE+NSE Vol: 750

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

750 (-44.44%) Volume

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

69.36%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

INR 14 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.28

stock-summary
Return on Equity

0.25%

stock-summary
Price to Book

0.67

Revenue and Profits (1 Year):
Net Sales:
3 Cr
(Quarterly Results - Mar 2023)
Net Profit:
-3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-54.67%
0%
-54.67%
1 Year
-65.69%
0%
-65.69%
2 Years
-59.8%
0%
-59.8%
3 Years
-81.23%
0%
-81.23%
4 Years
-85.77%
0%
-85.77%
5 Years
-72.55%
0%
-72.55%

Vanta Bioscience for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-7.20%
EBIT Growth (5y)
-1.12%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
3.00
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.19
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.51%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
24
Price to Book Value
0.67
EV to EBIT
15.89
EV to EBITDA
10.50
EV to Capital Employed
0.85
EV to Sales
4.49
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
5.37%
ROE (Latest)
0.25%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Mohan Krishna Mulakala (55.22%)

Highest Public shareholder

A Vimalchand (1.09%)

Individual Investors Holdings

26.55%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.47",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.79",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "1.91",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-2.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-22.77%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -70.99% vs -42.56% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -16.29% vs -229.63% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.03",
          "val2": "3.55",
          "chgp": "-70.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.38",
          "val2": "-0.75",
          "chgp": "49.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.14",
          "val2": "2.90",
          "chgp": "-26.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.07",
          "val2": "-1.78",
          "chgp": "-16.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-36.89%",
          "val2": "-21.13%",
          "chgp": "-15.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Mar 2023 is -53.48% vs 53.59% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Mar 2023 is -34.30% vs 31.17% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.48",
          "val2": "9.63",
          "chgp": "-53.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.23",
          "val2": "0.21",
          "chgp": "-1,161.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.54",
          "val2": "6.25",
          "chgp": "-11.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.99",
          "val2": "-4.46",
          "chgp": "-34.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-49.78%",
          "val2": "2.18%",
          "chgp": "-51.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 54.78% vs -35.19% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 64.20% vs -7,300.00% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.72",
          "val2": "6.28",
          "chgp": "54.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.31",
          "val2": "-2.39",
          "chgp": "154.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.75",
          "val2": "5.89",
          "chgp": "-2.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.32",
          "val2": "-6.48",
          "chgp": "64.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.48%",
          "val2": "-38.06%",
          "chgp": "51.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'23 - YoYstock-summary
Mar'23
Change(%)
Net Sales
3.47
NA
NA
Operating Profit (PBDIT) excl Other Income
-0.79
NA
NA
Interest
1.91
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
-2.73
NA
NA
Operating Profit Margin (Excl OI)
-22.77%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Mar'24
Change(%)
Net Sales
1.03
3.55
-70.99%
Operating Profit (PBDIT) excl Other Income
-0.38
-0.75
49.33%
Interest
2.14
2.90
-26.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.07
-1.78
-16.29%
Operating Profit Margin (Excl OI)
-36.89%
-21.13%
-15.76%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -70.99% vs -42.56% in Mar 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -16.29% vs -229.63% in Mar 2024

Nine Monthly Results Snapshot (Consolidated) - Mar'23stock-summary
Mar'23
Mar'23
Change(%)
Net Sales
4.48
9.63
-53.48%
Operating Profit (PBDIT) excl Other Income
-2.23
0.21
-1,161.90%
Interest
5.54
6.25
-11.36%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.99
-4.46
-34.30%
Operating Profit Margin (Excl OI)
-49.78%
2.18%
-51.96%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Mar 2023 is -53.48% vs 53.59% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Mar 2023 is -34.30% vs 31.17% in Mar 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
9.72
6.28
54.78%
Operating Profit (PBDIT) excl Other Income
1.31
-2.39
154.81%
Interest
5.75
5.89
-2.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.32
-6.48
64.20%
Operating Profit Margin (Excl OI)
13.48%
-38.06%
51.54%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 54.78% vs -35.19% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 64.20% vs -7,300.00% in Mar 2023

stock-summaryCompany CV
About Vanta Bioscience Ltd stock-summary
stock-summary
Vanta Bioscience Ltd
Micro Cap
Miscellaneous
Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name "Vanta Bioscience Private Limited"`. The Company converted into a Public Limited Company and the name was changed to "Vanta Bioscience Limited" on 17th March 2017. The Company is presently engaged in the business of Preclinical Activities.
Company Coordinates stock-summary
Company Details
No.02/G/308/G Umajay Complex, Rasoolpura Secunderabad Hyderabad Telangana : 500003
stock-summary
Tel: 91-40-66575454
stock-summary
info@vantabio.com
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad